- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Empaglifozin placebo Linagliptin placebo
Total 53855 results
-
John Paul II Hospital, KrakowNational Center for Research and Development, Poland; KCRICompleted
-
The University of Hong KongRecruitingType 2 Diabetes | Microvascular Coronary Artery DiseaseHong Kong
-
University College DublinCompletedType 2 Diabetes Mellitus | PsoriasisIreland
-
Merck Sharp & Dohme LLCCompletedDiabetes Mellitus, Type 2 | Renal Insufficiency, Chronic
-
Merck Sharp & Dohme LLCCompletedType 2 Diabetes Mellitus (T2DM)
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2United States, Canada, Thailand, Korea, Republic of, United Kingdom, China, Germany, Israel, Mexico, Argentina, Brazil, Colombia, Puerto Rico, Russian Federation
-
Ann & Robert H Lurie Children's Hospital of ChicagoNot yet recruitingNAFLD | Non-Alcoholic Fatty Liver Disease | Pediatric NAFLDUnited States
-
Centro Universitario de Ciencias de la Salud, MexicoActive, not recruitingDiabetes Mellitus Type 2 Without ComplicationMexico
-
Kallyope Inc.Completed
-
Khoo Teck Puat HospitalCompletedType II Diabetes in Subjects BMI 27 to 32Singapore
-
University of DiyalaCompleted
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, New Zealand, Spain, Japan, Finland, Germany, Greece, Romania, South Africa, Denmark, Colombia, Poland, United Kingdom, Mexico, Australia, Belgium, Ireland
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Australia, Canada, Denmark, Netherlands, Sweden
-
GWT-TUD GmbHTerminatedDiabetes Mellitus Type 2Germany
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2Argentina, Belgium, Canada, China, Germany, Korea, Republic of, Philippines, Russian Federation, Taiwan, Turkey, United Kingdom
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2Croatia, India, Israel, Italy, Malaysia, Netherlands, Poland, Romania, Slovakia, Thailand, Ukraine
-
AstraZenecaCompletedHeart Failure | Type 2 Diabetes MellitusUnited States, Thailand, Korea, Republic of, Russian Federation, Ukraine, Hungary, Bulgaria, Chile, Canada, Romania
-
Merck Sharp & Dohme LLCCompleted
-
Hoffmann-La RocheCompletedDiabetes Mellitus Type 2United States, France, Switzerland, Germany, South Africa, Korea, Republic of, Puerto Rico, Canada, Taiwan, Spain, Poland, Slovakia, Thailand, Mexico, Turkey, Australia, Greece, Norway, Sweden, Peru, Romania, Argentina, United Kingdom
-
Shengjing HospitalCompletedConstipation | Chinese Herbal MedicineChina
-
Steno Diabetes Center CopenhagenNovo Nordisk A/SUnknownType 2 Diabetes With Renal ManifestationsDenmark
-
AstraZenecaCompleted
-
Wake Forest University Health SciencesRecruitingCognitive Impairment | Alzheimer Disease | Mild Cognitive ImpairmentUnited States
-
Novartis PharmaceuticalsCompleted
-
Merck Sharp & Dohme LLCCompleted
-
Boehringer IngelheimEli Lilly and CompanyCompleted
-
LG Life SciencesCompletedType 2 DM Patients With Moderate or Severe Renal ImpairmentKorea, Republic of
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Germany, Spain, United States, Canada, Taiwan, Korea, Republic of, Finland, Denmark, France, Japan, Philippines, Vietnam
-
Centro Universitario de Ciencias de la Salud, MexicoUnknownType 2 Diabetes MellitusMexico
-
Albert Einstein College of MedicineCompletedChronic Kidney DiseaseUnited States
-
GlaxoSmithKlineCompletedDiabetes Mellitus, Type 2United States, Germany, Mexico, Peru, Russian Federation, United Kingdom, Philippines, South Africa, Spain, Hong Kong, Albania
-
Merck Sharp & Dohme LLCCompleted
-
SanofiCompletedType 2 Diabetes MellitusBrazil, Peru, United States, Australia, Canada, Chile, Germany, Guatemala, Mexico, Poland, Romania, Russian Federation, Ukraine
-
National Institute of Diabetes and Digestive and...WithdrawnDiabetic Kidney Disease | Diabetes Mellitus Type 2United States
-
University Hospital, Basel, SwitzerlandCompleted
-
Chinese PLA General HospitalUnknownReperfusion Injury, Myocardial
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Canada, India, Israel, Malaysia, Mexico, Philippines, Puerto Rico, Russian Federation, Sri Lanka, Thailand, Ukraine
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Japan
-
Henrik Enghusen PoulsenUniversity of Copenhagen; University Hospital, Gentofte, CopenhagenCompletedDiabetes Mellitus, Type 2Denmark
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Japan
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 1United States, Spain, Taiwan, Belgium, United Kingdom, Germany, Canada, Australia, Finland, Netherlands, Poland, France, Denmark, Norway, Sweden, Austria, Czechia
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Japan
-
The Catholic University of KoreaBayerCompletedType 2 Diabetes MellitusKorea, Republic of
-
National Institute on Aging (NIA)Completed
-
Boehringer IngelheimEli Lilly and CompanyCompletedObesity | Diabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1Canada
-
Merck Sharp & Dohme LLCCompletedType 2 Diabetes Mellitus
-
Merck Sharp & Dohme LLCCompletedDiabetes Mellitus, Non-Insulin-Dependent
-
University of VermontMerck Sharp & Dohme LLCUnknown
-
RWTH Aachen UniversityBoehringer IngelheimTerminated
-
University of Erlangen-Nürnberg Medical SchoolCompletedDiabetes Mellitus Type 2Germany